Patents by Inventor James Hurley
James Hurley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8653171Abstract: Plastisol compositions are disclosed containing methacrylate core/shell copolymer, non-phthalate ester plasticizers, pigment, filler, and thixotropic agent. Other additives are optional. The plasticizer is a blend of dibenzoate and DINCH. The plastisol can be used an ink of various colors for use in application to textiles. The plastisol compositions avoid polyvinyl chloride polymer resins and phthalate plasticizers conventionally employed in plastisol inks.Type: GrantFiled: February 16, 2011Date of Patent: February 18, 2014Assignee: PolyOne CorporationInventors: James Hurley, James Kevin Seagraves, Erik Saly
-
Patent number: 8564140Abstract: A conductive composition includes a mono-acid hybrid that includes an unprotected, single reactive group. The mono-acid hybrid may include substantially non-reactive groups elsewhere such that the mono-acid hybrid is functional as a chain terminator. Methods and devices using the compositions are also disclosed.Type: GrantFiled: September 25, 2009Date of Patent: October 22, 2013Assignee: Alpha Metals, Inc.Inventors: Rajan Hariharan, James Hurley, Senthil Kanagavel, Jose Quinones, Martin Sobczak, Deborah Makita
-
Patent number: 8410112Abstract: The present disclosure relates to pyrazine compounds of formula I: wherein L, n, R1, and R2 are as described in the specification. These compounds are useful as inhibitors of ATR protein kinase. The disclosure also relates to pharmaceutically acceptable compositions comprising the compounds of the disclosure; methods of treating of various diseases, disorders, and conditions using the compounds of the disclosure; processes for preparing the compounds of the disclosure; intermediates for the preparation of the compounds of the disclosure; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors.Type: GrantFiled: October 27, 2011Date of Patent: April 2, 2013Assignee: Vertex Pharmaceuticals IncorporatedInventors: Jean-Damien Charrier, Steven John Durrant, David Kay, Michael O'Donnell, Ronald Marcellus Alphonsus Knegtel, Somhairle MacCormick, Joanne Pinder, Stephen Clinton Young, Hayley Marie Binch, Thomas Cleveland, Lev Tyler Dewey Fanning, Dennis James Hurley, Pramod Joshi, Urvi Jagdishbhai Sheth, Alina Silina, Philip Michael Reaper, Anisa Nizarali Virani
-
Patent number: 8371519Abstract: A cord material dispenser comprising a container including a surrounding sidewall having first and second openings and first and second cord materials disposed in the container. The first and second cord materials are dispensable through their respective first and second openings. The first cord material is preferably wound around a first spool and the second cord material is preferably wound around a second spool. The dispenser may include a first quantity of the first cord material and a second quantity of the second cord material, wherein the first quantity is less than the second quantity. For example, the first quantity may be one fourth of the second quantity. Preferably, the container includes indicia indicative of the ratio of the first quantity to the second quantity. The indicia may be in the form of a graphic representative of the intended use of the spooled materials.Type: GrantFiled: April 13, 2010Date of Patent: February 12, 2013Assignee: Garlock Sealing Technologies LLCInventors: Michael W. McManus, Marc E. Semmler, Mari Foley, Matt Tones, Christian Lauzier, Chris Boss, Janet C. Jessen, Timothy James Hurley, David W. Reeves
-
Patent number: 8344147Abstract: The present invention relates to processes for preparing solid state forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1, 4-dihydroquinoline-3-carboxamide, including Compound 1 Form A, Compound 1 Form A-HCl, Compound 1 Form B, and Compound 1 Form B-HCl, any combination of these forms, pharmaceutical compositions thereof, and methods of treatment therewith.Type: GrantFiled: October 21, 2010Date of Patent: January 1, 2013Assignee: Vertex Pharmaceutical IncorporatedInventors: Narendra Bhalchandra Ambhaikar, Robert Hughes, Dennis James Hurley, Elaine Chungmin Lee, Benjamin Littler, Mehdi Numa, Stefanie Roeper, Urvi Sheth
-
Publication number: 20120309758Abstract: The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.Type: ApplicationFiled: June 8, 2012Publication date: December 6, 2012Applicant: Vertex Pharmaceuticals IncorporatedInventors: Urvi Sheth, Lev T.D. Fanning, Mehdi Numa, Hayley Binch, Dennis James Hurley, Jinglan Zhou, Sara S. Hadida Ruah, Anna R. Hazlewood, Alina Silina, Rajendran Vairagoundar, Fredrick F. Van Goor, Peter Diederik Jan Grootenhuis, Martyn C. Botfield
-
Publication number: 20120264749Abstract: The invention relates to morpholine spirocyclic piperidine amide compounds useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.Type: ApplicationFiled: March 13, 2012Publication date: October 18, 2012Inventors: Sara Sabina Hadida-Ruah, Hayley Marie Binch, Michael Paul DeNinno, Lev Tyler Dewey Fanning, Bryan A. Frieman, Peter Diederik Jan Grootenhuis, Nicole Hilgraf, Pramod Joshi, Edward Adam Kallel, Mark Thomas Miller, Joseph Pontillo, Alina Silina, Urvi Jagdishbhai Sheth, Dennis James Hurley, Vijayalaksmi Arumugam
-
Publication number: 20120040020Abstract: The present disclosure relates to pyrazine compounds of formula I: wherein L, n, R1, and R2 are as described in the specification. These compounds are useful as inhibitors of ATR protein kinase. The disclosure also relates to pharmaceutically acceptable compositions comprising the compounds of the disclosure; methods of treating of various diseases, disorders, and conditions using the compounds of the disclosure; processes for preparing the compounds of the disclosure; intermediates for the preparation of the compounds of the disclosure; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors.Type: ApplicationFiled: October 27, 2011Publication date: February 16, 2012Applicant: Vertex Pharmaceuticals IncorporatedInventors: Jean-Damien Charrier, Steven John Durrant, David Kay, Michael O'Donnell, Ronald Marcellus Alphonsus Knegtel, Somhairle MacCormick, Joanne Pinder, Stephen Clinton Young, Haley Marie Binch, Thomas Cleveland, Lev Tyler Dewey Fanning, Dennis James Hurley, Pramod Joshi, Urvi Jagdishbhai Sheth, Alina Silina, Philip Michael Reaper, Anisa Nizarali Virani
-
Publication number: 20120027874Abstract: The present invention relates to pyrazine and pyridine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula I: wherein the variables are as defined herein.Type: ApplicationFiled: May 12, 2011Publication date: February 2, 2012Applicant: Vertex Pharmaceuticals IncorporatedInventors: Jean-Damien Charrier, Hayley Marie Binch, Dennis James Hurley, Thomas Cleveland, Pramod Joshi, Lev Tyler Dewey Fanning, Joanne Pinder, Michael O'Donnell, Anisa Nizarali Virani, Ronald Marcellus Alphonsus Knegtel, Steven John Durrant, Stephen Clinton Young, Pierre-Henri Storck, David Kay, Philip Michael Reaper
-
Publication number: 20110297252Abstract: An improved pilot valve assembly (14) for hydraulically controlling a pressure reducing valve (12) to maintain and further vary the outlet pressure (P2) of the pressure reducing valve (12) in response to increased flow (f) through the valve (12). The pilot valve assembly (14) comprising first and second movable valve members (100,102). The first and second moveable members (100,102) being acted on by a velocity head pressure sensed by a downstream Pitot tube (90) and a downstream outlet pressure (P2) in a balanced arrangement such that they move in response to both the velocity head and downstream pressure (P2) to open and close the pilot valve (14) and so main valve (12) to both maintain and vary the outlet pressure (P2).Type: ApplicationFiled: June 13, 2008Publication date: December 8, 2011Applicant: Aquavent UK LimitedInventors: Richard James Hurley, Mark Nicholas Lock, John Henry May
-
Publication number: 20110206907Abstract: Plastisol compositions are disclosed containing methacrylate core/shell copolymer, non-phthalate ester plasticizers, pigment, filler, and thixotropic agent. Other additives are optional. The plasticizer is a blend of dibenzoate and DINCH. The plastisol can be used an ink of various colors for use in application to textiles. The plastisol compositions avoid polyvinyl chloride polymer resins and phthalate plasticizers conventionally employed in plastisol inks.Type: ApplicationFiled: February 16, 2011Publication date: August 25, 2011Applicant: POLYONE CORPORATIONInventors: James HURLEY, J. Kevin SEAGRAVES, Erik SALY
-
Publication number: 20110124869Abstract: The present invention relates to processes for preparing solid state forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide, including Compound 1 Form A, Compound 1 Form A-HCl, Compound 1 Form B, and Compound 1 Form B-HCl, any combination of these forms, pharmaceutical compositions thereof, and methods of treatment therewith.Type: ApplicationFiled: October 21, 2010Publication date: May 26, 2011Applicant: Vertex Pharmaceuticals IncorporatedInventors: Narendra Bhalchandra Ambhaikar, Robert Hughes, Dennis James Hurley, Elaine Chungmin Lee, Benjamin Littler, Mehdi Numa, Stefanie Roeper, Urvi Sheth
-
Publication number: 20110070027Abstract: A principal catch basin defining a certain storage capacity, the catch basin situated below the level of the ground, having an upper level opening for receiving surface water drainage thereunto, and having side walls partially constructed of permeable geotextile fabric for allowing water flow into the permeable basin to serve as a collection for sub-surface drainage. The system would include the ability to automatically pump the drainage water out using the energy of a pressurized water system in conjunction with a venturi pump without the need of any electrical sensors or signals. In addition, there may be a plurality of collection basins which could be joined together as a system to pump the water from various locations through one transport line.Type: ApplicationFiled: July 15, 2010Publication date: March 24, 2011Inventor: Dennis James Hurley
-
Publication number: 20100320310Abstract: A cord material dispenser comprising a container including a surrounding sidewall having first and second openings and first and second cord materials disposed in the container. The first and second cord materials are dispensable through their respective first and second openings. The first cord material is preferably wound around a first spool and the second cord material is preferably wound around a second spool. The dispenser may include a first quantity of the first cord material and a second quantity of the second cord material, wherein the first quantity is less than the second quantity. For example, the first quantity may be one fourth of the second quantity. Preferably, the container includes indicia indicative of the ratio of the first quantity to the second quantity. The indicia may be in the form of a graphic representative of the intended use of the spooled materials.Type: ApplicationFiled: April 13, 2010Publication date: December 23, 2010Applicant: Garlock Sealing Technologies LLCInventors: Michael W. McManus, Marc E. Semmler, Mari Foley, Matt Tones, Christian Lauzier, Chris Boss, Janet C. Jessen, Timothy James Hurley, David W. Reeves
-
Patent number: 7751785Abstract: A system and method for wireless communication. The system can include a transmitter that transmits a data signal having a time period without data transmission. The system can also include a receiver including a first antenna, a second antenna, a switch that activates one of the first antenna and the second antenna, and a processor that estimates a first signal-to-noise ratio for the first antenna and a second signal-to-noise ratio for the second antenna during the time period without data transmission. The processor can control the switch to select one of the first antenna and the second antenna based on a comparison between the first signal-to-noise ratio and the second signal-to-noise ratio.Type: GrantFiled: April 18, 2007Date of Patent: July 6, 2010Assignee: GE Medical Systems Information Technologies, Inc.Inventors: Karina P. Carvalho, Neal J. Seidl, Matthew G. Grubis, Ralph T. Hoctor, James Hurley, Russell A. Rymut
-
Publication number: 20100084757Abstract: A conductive composition includes a mono-acid hybrid that includes an unprotected, single reactive group. The mono-acid hybrid may include substantially non-reactive groups elsewhere such that the mono-acid hybrid is functional as a chain terminator. Methods and devices using the compositions are also disclosed.Type: ApplicationFiled: September 25, 2009Publication date: April 8, 2010Inventors: Rajan Hariharan, James Hurley, Senthil Kanagavel, Jose Quinones, Martin Sobczak, Deborah Makita
-
Patent number: 7475308Abstract: A method, apparatus and computer program product are provided for implementing deterministic based broken scan chain diagnostics. A deterministic test pattern is generated and is loaded into each scan chain in the device under test using lateral insertion via system data ports applying system clocks. Then each scan chain is unloaded and a last switching latch is identified. The testing steps are repeated a selected number of times. Then checking for consistent results is performed. When consistent results are identified, then the identified last switching latch is sent to a Physical Failure Analysis system.Type: GrantFiled: April 11, 2008Date of Patent: January 6, 2009Assignee: International Business Machines CorporationInventors: Adrian C. Anderson, Todd Michael Burdine, Donato Orazio Forlenza, Orazio Pasquale Forlenza, William James Hurley, Phong T. Tran
-
Patent number: 7465738Abstract: The present invention relates to compounds useful as promoters of the SMN2 gene. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of Spinal Muscular Atrophy.Type: GrantFiled: June 16, 2004Date of Patent: December 16, 2008Assignee: Vertex Pharmaceuticals IncorporatedInventors: Jill Jarecki, Xiaocun Chen, Dennis James Hurley, Lewis R. Makings, Mark T. Miller, Brian Pollok, Jeffrey H. Stack, Michael A. Whitney
-
Publication number: 20080189583Abstract: A method, apparatus and computer program product are provided for implementing deterministic based broken scan chain diagnostics. A deterministic test pattern is generated and is loaded into each scan chain in the device under test using lateral insertion via system data ports applying system clocks. Then each scan chain is unloaded and a last switching latch is identified. The testing steps are repeated a selected number of times. Then checking for consistent results is performed. When consistent results are identified, then the identified last switching latch is sent to a Physical Failure Analysis system.Type: ApplicationFiled: April 11, 2008Publication date: August 7, 2008Applicant: International Business Machines CorporationInventors: Adrian C. Anderson, Todd Michael Burdine, Donato Orazio Forlenza, Orazio Pasquale Forlenza, William James Hurley, Phong T. Tran
-
Patent number: 7395469Abstract: A method, apparatus and computer program product are provided for implementing deterministic based broken scan chain diagnostics. A deterministic test pattern is generated and is loaded into each scan chain in the device under test using lateral insertion via system data ports applying system clocks. Then each scan chain is unloaded and a last switching latch is identified. The testing steps are repeated a selected number of times. Then checking for consistent results is performed. When consistent results are identified, then the identified last switching latch is sent to a Physical Failure Analysis system.Type: GrantFiled: April 8, 2004Date of Patent: July 1, 2008Assignee: International Business Machines CorporationInventors: Adrian C. Anderson, Todd Michael Burdine, Donato Orazio Forlenza, Orazio Pasquale Forlenza, William James Hurley, Phong T. Tran